HealthMore in Health →
GLP-1 Heart Benefits Hold Up in Long-Term Review
A review of 11 major cardiovascular trials found GLP-1 receptor agonists were linked to fewer heart attacks, strokes, and cardiovascular deaths over nearly three years of follow-up, extending the case for the drugs wellb
Key Takeaways
- A long-term review of 11 trials linked GLP-1 drugs to lower rates of heart attack, stroke, and cardiovascular death.
- The analysis covered more than 90,000 patients and focused only on studies with at least one year of follow-up.
DE
DT Editorial AI··via medicalxpress.com